The goal of this pilot randomized controlled trial is to determine if a randomized controlled trial of a collaborative pharmacist-intensivist telehealth follow-up after intensive care unit discharge can feasibly be performed in patients who have survived a critical illness. The study intervention will be telehealth follow-up appointments provided by clinical pharmacists at approximately one and three months post-hospital discharge. The purpose of the follow-up appointments will be to assess for post-intensive care syndrome and provide recommend interventions aimed at improving recovery Participants will randomized to receive the study intervention or standard of care.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
24
The post-ICU clinic follow-up will be conducted by a pharmacist via a telehealth visit. A collaborating physician (i.e. intensivist) will provide clinical support and oversight as needed. The appointments will be 30-60 minute telephone/video calls. Participants be assessed for PICS and recommended interventions to improve their care.
Malcom Randall Veterans Affairs Medical Center
Gainesville, Florida, United States
RECRUITINGCompletion of Post-ICU follow-up
Percentage of patients completing post-ICU follow-up
Time frame: From enrollment to end of follow-up period at seven months
Quality of life at 6 months using the Short Form Survey (SF-36)
Medical Outcomes Study (MOS) 36-Item Short Form Health Survey (SF-36). Scores 0-100, higher scores indicating more favorable health state.
Time frame: From enrollment to 7 months
Hospital or ICU re-admissions
Time frame: Enrollment up to 7 months
Emergency department visits
Time frame: Enrollment up to 7 months
Mortality
Time frame: within 6 months post-hospital discharge
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.